Phase II study of weekly irinotecan (CPT-11) as second-line treatment of patients with advanced colorectal cancer

1. Cassinello, J.
2. López-Alvarez, P.
3. Martínez-Guisado, A.
4. Valladares, M.
5. Huidobro, G.
6. López, R.
7. Bohn, U.
8. Sevilla, I.
9. Ballesteros, P.
10. Jorge, M.
11. Pérez-Carrión, R.
12. Fernández, J.L.
13. Dorta, J.